Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01772797
Title Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications

lung non-small cell carcinoma

Therapies

Ceritinib

Luminespib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Dept. of Anschutz Cancer (3) Aurora Colorado 80045 United States Details
Massachusetts General Hospital Mass General Boston Massachusetts 02114 United States Details
Fox Chase Cancer Center Fox Chase Cancer (2) Philadelphia Pennsylvania 19111-2497 United States Details
University of Utah / Huntsman Cancer Institute Huntsman Salt Lake City Utah 84103 United States Details
Novartis Investigative Site Melbourne Victoria 3000 Australia Details
Novartis Investigative Site Milano MI 20141 Italy Details
Novartis Investigative Site Singapore 169610 Singapore Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field